VakSea
Fabricante · Baltimore, Estados Unidos · Desde 2016 · 1–10 empleados
Affordable oral vaccine platform
- Productos
- 1
- Orígenes
- —
- Certificaciones verificadas
- 0
- Ofertas activas
- 0
- Mercados de exportación
- —
Acerca de
VakSea has developed an innovative system that uses insect larvae to affordably produce specialty, immune-boosting proteins that can be delivered orally and have been shown to reduce disease-related losses in both fish and shrimp. VakSea is creating a range of protein-based products to reduce mortality caused by diseases in aquaculture and to increase yields.
Productos1
Los perfiles sin reclamar se elaboran con datos públicos de la empresa y pueden estar incompletos o desactualizados. Confirme siempre los datos con la empresa. Todos los proveedores